SOURCE: Medistem Laboratories

October 30, 2007 13:26 ET

Medistem Laboratories to Present at the University of Latvia's International Conference on Stem Cells and Cell Therapy

SCOTTSDALE, AZ--(Marketwire - October 30, 2007) - Medistem Laboratories (OTCBB: MDSM) announced today that Thomas Ichim, Chief of Scientific Development, will present at an International stem cell conference being put on by the University of Latvia on November 2, 2007. Ichim's talk will address recent results from Medistem's basic research and pre-clinical activities surrounding the Tolerostem and Angiostem platforms.

About Medistem Laboratories, Inc.

Medistem Laboratories is a biotechnology company that discovers, develops, and commercializes adult stem cell products that address serious medical conditions. While drug discovery and development is its primary focus, Medistem has compiled a body of proprietary technologies it outlicenses to commercial entities in markets where stem cell administration is permissible. Due to its licensee relationships and collaborative efforts with respected institutions, Medistem believes it is well positioned to be a leading developer of adult stem cell products.

Contact Information